Bayshore Pharmaceuticals
  • About Us
  • Our Business
  • Products
  • Contact
  • LinkedIn

Announcement

Visit Us at NACDS TSE 2022: Booth 1710

June 2, 2022 By Brittney Guida In Announcement /  

Bayshore Pharmaceuticals as featured on Inside The Blueprint Local NY

October 23, 2021 By Brittney Guida In Announcement /  

Beximco Pharmaceuticals- Setting The Bar High for Generic Medicines

September 22, 2021 By Brittney Guida In Announcement /  

Bayshore Pharmaceuticals Granted Etodolac ANDA Approvals

December 22, 2020 By Brittney Guida In Announcement /  

Beximco Pharma receives US FDA approval for Flecainide Acetate Tabs

September 22, 2020 By Brittney Guida In Announcement /  

Bayshore Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

August 19, 2020 By Brittney Guida In Announcement /  

NACDS 2020, San Diego, August 8 – 10, Booth 2006

January 1, 2020 By Brittney Guida In Announcement /  

Bayshore Pharmaceuticals Announces Launch of Carvedilol Tablets

November 16, 2016 By mark.moshier In Announcement /  

Bayshore India

March 11, 2016 By mark.moshier In Announcement /  

Come visit us at DCAT New York on March 14-18, 2016

March 9, 2016 By contemplate In Announcement /  1

Posts navigation

1 2

Bayshore Pharmaceuticals

One Tower Center Boulevard, Suite 2200
East Brunswick, NJ 08816

732-253-5954

© Bayshore Pharmaceuticals. All rights reserved. | Admin | Site by Contemplate Design